Standout Papers

The effects of the novel,... 2001 2026 2009 2017 2001 100 200 300 400 500

Immediate Impact

3 by Nobel laureates 19 from Science/Nature 92 hit
Sub-graph 1 of 20

Citing Papers

Antitumour immunity regulated by aberrant ERBB family signalling
2021 Hit
Synthon-based ligand discovery in virtual libraries of over 11 billion compounds
2021 HitNature
11 intermediate papers

Works of Karen Affleck being referenced

Indazolylamino quinazolines and pyridopyrimidines as inhibitors of the EGFr and c-erbB-2
2001
The effects of the novel, reversible epidermal growth factor receptor/ErbB-2 tyrosine kinase inhibitor, GW2016, on the growth of human normal and tumor-derived cell lines in vitro and in vivo.
2001 Hit
and 2 more

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Karen Affleck 568 490 315 202 139 24 1.2k
Sally A. Prigent 483 0.9× 776 1.6× 100 0.3× 151 0.7× 31 0.2× 23 1.3k
Melody Stallings‐Mann 464 0.8× 649 1.3× 89 0.3× 41 0.2× 112 0.8× 40 1.2k
Michelle M. Williams 294 0.5× 792 1.6× 197 0.6× 156 0.8× 83 0.6× 41 1.5k
Françoise Capony 292 0.5× 588 1.2× 155 0.5× 70 0.3× 292 2.1× 31 1.4k
Punit Saraon 233 0.4× 799 1.6× 238 0.8× 44 0.2× 63 0.5× 25 1.5k
Shannon L. Wyszomierski 538 0.9× 745 1.5× 83 0.3× 101 0.5× 27 0.2× 18 1.2k
Lluís López-Barcons 305 0.5× 739 1.5× 188 0.6× 37 0.2× 46 0.3× 44 1.3k
Harald Dinter 233 0.4× 590 1.2× 84 0.3× 40 0.2× 72 0.5× 22 1.1k
Iwao Waga 146 0.3× 719 1.5× 142 0.5× 41 0.2× 96 0.7× 31 1.3k
Claudine Tardy 372 0.7× 799 1.6× 166 0.5× 33 0.2× 84 0.6× 19 1.2k

All Works

Loading papers...

Rankless by CCL
2026